Options Brief: Savient Pharmaceuticals (SVNT)

Shares of Savient Pharmaceuticals, Inc. SVNT are lower on the session by 9.25%, trading at $10.05. Overall call volume is now running at 2.69x the daily average, with 55% of all calls traded being purchases on the offer. 2,105 contracts have traded on the session so far. Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union.